47
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome

&
Pages 1287-1294 | Accepted 18 May 2006, Published online: 01 Jun 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pantelis A. Sarafidis, Maria Eleni Alexandrou & Luis M. Ruilope. (2017) A review of chemical therapies for treating diabetic hypertension. Expert Opinion on Pharmacotherapy 18:9, pages 909-923.
Read now

Articles from other publishers (6)

Nesreen M. I. M. Elkomy, Islam A. A. E. ‐H. Ibrahim, Hassan M. El‐Fayoumi & Shimaa M. Elshazly. (2020) Effect of imidazoline‐1 receptor agonists on renal dysfunction in rats associated with chronic, sequential fructose and ethanol administration. Clinical and Experimental Pharmacology and Physiology 47:4, pages 609-619.
Crossref
Dayton M. Petibone, Waqar Majeed & Daniel A. Casciano. (2017) Autophagy function and its relationship to pathology, clinical applications, drug metabolism and toxicity. Journal of Applied Toxicology 37:1, pages 23-37.
Crossref
Anna Masajtis-Zagajewska, Jacek Majer & Michał Nowicki. (2010) Effect of moxonidine and amlodipine on serum YKL-40, plasma lipids and insulin sensitivity in insulin-resistant hypertensive patients—a randomized, crossover trial. Hypertension Research 33:4, pages 348-353.
Crossref
Italo Biaggioni. (2008) Should We Target the Sympathetic Nervous System in the Treatment of Obesity-Associated Hypertension?. Hypertension 51:2, pages 168-171.
Crossref
Pantelis A. Sarafidis, Samy I. McFarlane & George L. Bakris. (2007) Antihypertensive agents, insulin sensitivity, and new-onset diabetes. Current Diabetes Reports 7:3, pages 191-199.
Crossref
Robert Feneck. (2007) Drugs for the Perioperative Control of Hypertension. Drugs 67:14, pages 2023-2044.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.